http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Suh, Hyeon Jeong,Yoon, Seo Hyun,Yu, Kyung-Sang,Cho, Joo-Youn,Park, Sang-In,Lee, Eunyoung,Lee, Jeong-Ok,Koh, Youngil,Song, Kyoung-Ho,Choe, Pyoeng Gyun,Kim, Eu Suk,Bang, Soo-Mee,Kim, Hong Bin,Kim, Inho American Society for Microbiology 2018 Antimicrobial Agents and Chemotherapy Vol.62 No.7
<P>The metabolism of posaconazole is mediated mainly by uridine 5'diphospho-glucuronosyltransferase (UGT) enzymes, especially UGT1A4. The aim of this study was to investigate the effects of genetic polymorphisms on the posaconazole plasma concentration (PPC). This prospective study was conducted from September 2014 to August 2016. We enrolled patients with acute myeloid leukemia or myelodysplastic syndrome treated with posaconazole oral suspension (200 mg) three times daily for fungal prophylaxis. The patients were examined for the multidrug resistance gene 1 3435C>T and 2677G>T/A variations and the UGT1A4*3 allele by direct sequencing of DNA from peripheral whole-blood samples. We defined poor absorbers to be those with PPCs of <200 ng/ml and the optimal PPC to be >= 700 ng/ml on day 8. The associations between genetic polymorphisms and the PPC were evaluated using multivariate logistic regression analysis including clinical variables. During the study period, 132 patients were enrolled. Six patients (4.5%) were defined as poor absorbers, and 49 patients (37.1%) did not reach the optimal PPC on day 8. In multivariate analysis, the independent risk factors for a poor absorber were at least one UGT1A4*3 allele (adjusted odds ratio (aOR], 18.81; 95% confidence interval [Cl], 1.09 to 324.44; P = 0.043) and poor oral food intake (aOR per -100 kcal, 1.44; 95% Cl, 1.04 to 1.99; P = 0.029). There was no statistically significant association between the genetic polymorphisms and achievement of the optimal PPC on day 8. The UGT1A4*3 polymorphism is an independent risk factor for being a poor absorber of posaconazole oral suspension in patients with hematological malignancies.</P>
Suh, Hyeon Jeong,Kim, Inho,Cho, Joo-Youn,Park, Sang-In,Yoon, Seo Hyun,Hwang, Joo-Hee,Bae, Ji Yun,Lee, Jeong-Ok,Koh, Youngil,Song, Kyoung-Ho,Choe, Pyoeng Gyun,Yu, Kyung-Sang,Kim, Eu Suk,Kim, Hong Bin,B Raven Press 2018 Therapeutic drug monitoring Vol.40 No.1
BACKGROUND:: Therapeutic drug monitoring (TDM) of posaconazole is usually performed 1 week after starting the drug because of its long half-life. However, previous studies showed that measuring the posaconazole plasma concentration (PPC) on day 3 is effective for predicting steady-state levels. The purpose of this study was to evaluate the relevance of early TDM (day 3) of posaconazole for achieving an optimal PPC. METHODS:: This prospective study was conducted from September 2014 to August 2016. A total of 148 patients with acute myeloid leukemia or myelodysplastic syndromes received a 200 mg posaconazole oral suspension 3 times daily for fungal prophylaxis. During the period from September 2014 to December 2015 (control group), no dose adjustment was performed on day 3. During the period from January 2016 to Aug 2016 (early TDM group), the frequency of posaconazole 200-mg administration was increased to 4 times daily in patients whose PPC on day 3 was <400 ng/mL. The cutoff value for optimal PPC on day 8 was defined as 500 ng/mL. RESULTS:: In 21 of 107 patients (20%) in the control group, PPC was <400 ng/mL on day 3. In 15 (71%) of these 21 patients, the PPC was suboptimal on day 8. In the early TDM group, the PPC was <400 ng/mL on day 3 in 4 of 41 patients (10%). After increasing the posaconazole administration frequency in these 4 patients, PPC was suboptimal on day 8 in 1 patient (25%). In both groups, 104 patients had a PPC of ≥500 ng/mL on day 3, but 7% (7/104) of these had a suboptimal level on day 8. CONCLUSIONS:: Early TDM on day 3 for posaconazole suspension may help more patients achieve optimal drug levels on day 8, although TDM on day 8 is needed even in patients with optimal levels on day 3.
Enhancement of exercise endurance capacity by fermented deer antler in BALB/c mice.
Jang, Seongho,Park, Eu Ddeum,Suh, Hyung Joo,Lee, Sang Hun,Kim, Jin Soo,Park, Yooheon Japan Society for Bioscience, Biotechnology, and A 2014 Bioscience, Biotechnology, and Biochemistry Vol.78 No.10
<P>To investigate the activity of fermented deer antler on exercise endurance capacity, we evaluated endurance capacity in five-week-old male BALB/c mice by administering the fermented deer antler extract (FA) or the non-fermented deer antler extract (NFA) and then subjected the mice to exercise in the form of swimming. The mice administered 500 mg/kg/day of FA showed a significant increase in swimming time compared with mice administered placebo (16.55 min vs. 21.64 min, P<0.05). Serum lactate dehydrogenase (LDH), the marker of the liver and muscle damage, was significantly lower in FA groups. However, NFA groups did not show significantly different swimming time or serum LDH from that of the control group. Moreover, the FA-500 group had significantly higher hepatic superoxide dismutase (SOD) activity after forced swimming than the control and NFA groups (P<0.05). These findings suggest that fermentation may increase the exercise endurance capacity of the deer antler.</P>
Ahn, Sang-Woon,Park, Eu-Suh,Lee, Kee-Hag Korean Chemical Society 1981 Bulletin of the Korean Chemical Society Vol.2 No.3
A calculation method of the dipole moments for square planar and tetrahedral complexes by the valence bond method has been developed and an example calculation was carried out choosing the square planar and tetrahedral $[M(Ⅱ)N_2Se_2]$ type complexes. The calculated values of the dipole moments by the valence bond method are higher than those of the approximate orbital method. We found that we may predict the geometric structure of the transition metal complexes comparing the calculated values of the dipole moments with the experimental values. A new method for definition of C' parameter has also developed on the basis of extended Huckel theory.
박으뜸,박유헌,박성선,서형주,Park, Eu Deum,Park, Yooheon,Park, Sung-Sun,Suh, Hyung-Joo 한국식품영양학회 2012 韓國食品營養學會誌 Vol.25 No.4
본 연구에서는 혈액 내에서의 오메가-3 지방산의 함량 변화를 측정하여 연질 캡슐과 장용성 캡슐의 차이를 검토하였다. Fish oil 중의 EPA와 DHA의 총합의 함량이 62.87 g/100 g으로 대부분을 차지하고 있다. 연질 캡슐의 경우, 제 1시험액(위액)에서는 내부의 지방이 70% 용출된 반면, 장용성의 경우 10% 정도만이 용출되었다. 제 2액(소장액)에서도 6시간까지 50% 정도 용출되어 90분에 50%가 용출된 일반 연질 캡슐과 대조적이었다. 기존에 사용하였던 연질 캡슐의 EPA 및 DHA는 흡수 초기에 장용성 캡슐에 비하여 다소 높은 비율을 보인 반면, 8시간 이후 장용성 캡슐 섭취한 경우 EPA와 DHA의 혈액내 함량이 비율이 증가하는 경향을 보였다. 경구 투여 48시간 후 지방산 조성은 장용성 캡슐에서는 mono-, poly-unsaturated fatty acid 혈액 내의 함량이 다소 높은 경향을 보였으며, saturated fatty acid 함량 역시 다소 높은 경향을 보였다. EPA와 DHA의 함량은 혈액 내에서 각 지방 분획에서의 함량 차이를 정확하게 측정하기 힘들었다. 이상의 결과에 의하면 장용성 캡슐은 위장관을 통과하여 장에서 용출되는 특성 때문에 지속적인 효과를 기대할 수 있을 것으로 추정된다. We investigate the changes of fatty acids in blood for an evaluation of the effects of soft and enteric coated capsules containing omega 3 fatty acids. Fish oil, which contained 62.87 g/100 g of sum of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), was used as nutracueticals for omega 3 fatty acids. Lipid releasing amount in soft capsule was 70% in stomach condition. However, there was 10% of releasing amount of lipid observed in enteric coated capsule in stomach condition. In intestinal condition, 50% of lipid releasing amount in enteric coated capsule showed until 6 hr, but soft capsule until 90 min. EPA and DHA contents in soft capsule administration showed higher level than those in enteric coated capsule until 8 hr. However, the administration of enteric coated capsule showed higher level of EPA and DHA in blood after 8 hr. After 24 hr, mono-, poly-unsaturated and saturated fatty acids contents with enteric coated capsule showed higher level than those with soft capsule. The enteric coated capsule containing omega 3 fatty acids was expected to sustain omega 3 fatty acids.
안상운,박의서,최창진,Sangwoon Ahn,Eu Suh Park,Chang Jin Choi Korean Chemical Society 1983 대한화학회지 Vol.27 No.2
EHT calculation의 고유함수를 사용하여 $[M(II)O_3N_3]$ 및 $[Ni(II) O_2N_4]$ 형태착물[M(II) = Co(III), Ni(II) 및 Cu(II)]의 쌍극자 모멘트에 대한 cis 및 trans 구조의 영향을 고찰하였다. cis$[M(Ⅱ)O_3N_3]$ 형태착물의 계산한 쌍극자 모멘트가 trans착물의 계산한 쌍극자 모멘트 값보다 큰 값을 가지며 trans 착물의 쌍극자 모멘트 값이 실험치 범위안에 들었다. 그러나 $[Ni(II) O_2N_4]$ 착물의 경우 cis 착물의 쌍극자 모멘트 값이 실험치 범위안에 들었다. 이 결과는 $[Co(III)O_3N_3]$ 형태착물이 trans 구조, $[Ni(II) O_2N_4]$ 형태착물은 cis 구조를 가졌음을 암시하며 이는 실험결과와 일치한다. $[M(II)O_3N_3]$ 형태착물에서 세개의 두자리 (O-N)리간드가 금속이온에 배위되어 있으며 $[Ni(II) O_2N_4]$형태 착물에서는 두개의 세자리(O-N-N) 리간드가 Ni(II) 이온에 배위되어 있음). The effects of cis and trans configurations of ligands for $[M(II)O_3N_3]$ and $[Ni(II) O_2N_4]$ type complexes [M(II) = Co(III), Ni(II) and Cu(II)] on the calculated dipole moments have been investigated, adpoting the eigenvectors of EHT calculation. The calculated dipole moments for cis complexes are higher than those of trans complexes. The calculated dipole moments for the octahedral trans $[Co(III)O_3N_3]$ type complex fall in the range of experimental values. However the calculated dipole moments for cis $[Ni(II) O_2N_4]$ type complexes fall in the range of the experimental values. These results predicts the trans structure for $[Co(III)O_3N_3]$ and $[Ni(II) O_2N_4]$ type complexes. Those structures are in agreement with the experimental one (Three bidentate (O-N) ligands in $[M(II)O_3N_3]$ type complexes coordinate to the metal ion and two tridentate (O-N-N) ligands in [Ni(II)O2N4] type complexes coordinate to Ni(II) ion).
전이원소착물의 자기모멘트의 계산 (제1보). 일그러진 팔면체 $[Ti(III)A_3B_3]$형태 착물의 자기모멘트 [A 및 B = Cl, O, N, Br]
안상운,박의서,박병빈,Sangwoon Ahn,Eu Suh Park,Byung Bin Park 대한화학회 1980 대한화학회지 Vol.24 No.2
축방향대칭을 갖는 팔면체 $[Ti(III)A_3B_3]$형태 착물의 자기모멘트를 계산하는 식을 유도하여 distortion parameter$({\delta})$, 스핀-궤도 상호작용상수$({\zeta}')$ 및 orbital reduction factor의 실험치를 사용하여 이들 착물의 자기모멘트를 계산하였다. 축방향으로 일그러진 팔면체 $[Ti(III)A_3B_3]$형태 착물의 계산한 자기모멘트가 실험치와 비교적 일치하였다. 팔면체로부터 축방향 일그러짐이 커짐에 따라 그리고 orbital reduction factor가 감소함에 따라 계산한 자기모멘트의 값이 크게 감소하였다. 축방향대칭보다 낮은 리간드장으로 일그러진 팔면체착물의 자기모멘트를 계산하는 방법을 발전시켰으며 계산한 자기모멘트를 기초로 하여 일그러진 팔면체 $[Ti(III)A_3B_3]$형태 착물의 구조를 논의하였다. A formula for calculation of the magnetic moments for octahedral $[Ti(III)A_3B_3]$ type complexes with axial symmetry has been developed and the magnetic moments for these complexes are calculated, using the experimental values of the distortion parameters$({\delta})$, spin-orbit coupling constants and orbital reduction factors. The calculated magnetic moments for axially distorted octahedral $[Ti(III)A_3B_3]$ type complexes are in resonable agreement with the experimental valuest It is found that the calculated magnetic moments decrease as the extent of axial distortion increases and the orbital reduction factor decreases. A calculation method of the magnetic moments for octahedral $[Ti(III)A_3B_3]$ type complexes which are in a ligand field of lower than axial symmetry has also been developed and the structure of distorted octahedral $[Ti(III)A_3B_3]$ type complexes are discussed on the basis of the of the calculated magnetic moments.